Table 1.
Study | Selective Head CoolCap [8] | Whole-Body NICHD[9] | Whole-body TOBY trial[10] | Selective Head Chinese trial [11] | ||||
---|---|---|---|---|---|---|---|---|
Cooled | Control | Cooled | Control | Cooled | Control | Cooled | Control | |
Increased Liver Enzymes | 38%* | 53% | 20% | 15% | NR | NR | 35% | 28% |
Thrombocytopenia | 33% | 22% | NR | NR | 58% | 50% | 6% | 2% |
Prolonged coagulation | 50% | 42% | 18% | 11% | 41% | 43% | NR | NR |
Hemorrhage/Bleeding | NR | NR | 3% | 2% | NR | NR | 3% | 2% |
Renal Failure | 65% | 70% | 22% | 26% | ND | ND | 23% | 22% |
P<0.05 verses control infants;
NR=not reported; ND= none requiring dialysis